Get Premium to unlock powerful stock data
NAS:IMVT (USA)  
Immunovant Inc logo

Immunovant Inc

$ 3.98 +0.08 (+2.05%) 08:08 PM EST
P/E:
At Loss
P/B:
0.99
Market Cap:
$ 463.74M
Enterprise V:
$ -27.72M
Volume:
169.95K
Avg Vol (2M):
357.18K
Volume:
169.95K
Market Cap $:
463.74M
PE Ratio:
At Loss
Avg Vol (2-Month):
357.18K
Enterprise Value $:
-27.72M
PB Ratio:
0.99
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Immunovant Inc
NAICS : 325199 SIC : 2834
320 West 37th Street, 6th Floor, New York, NY, USA, 10018
Description
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).
Name Current Vs Industry Vs History
Cash-To-Debt 208.89
Equity-to-Asset 0.91
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate 1163.4
Name Current Vs Industry Vs History
5-Day RSI 52.44
9-Day RSI 52.65
14-Day RSI 50.39
6-1 Month Momentum % -51.76
12-1 Month Momentum % -63.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.52
Quick Ratio 11.52
Cash Ratio 11.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -100.9

Financials (Next Earnings Date:2022-08-05 Est.)

IMVT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:IMVT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.43
Beta 1.04
Volatility % 31.77
14-Day RSI 50.39
14-Day ATR ($) 0.265767
20-Day SMA ($) 3.8605
12-1 Month Momentum % -63.85
52-Week Range ($) 3.145 - 11.37
Shares Outstanding (Mil) 116.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immunovant Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More